Mammoth Biosciences
Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
About
Technology stack
detected 2026-06-16No comments yet. Be the first to share your take.
What does Mammoth Biosciences do?
Mammoth Biosciences is developing in vivo gene editing therapeutics using novel CRISPR-Cas enzymes and protein discovery technologies to deliver permanent cures for serious diseases. Their platform also enables limitless testing possibilities through a revolutionary CRISPR-based molecular diagnostics system. The company serves patients by overcoming challenges in genetic medicine and addressing unmet needs for severe conditions.
How much funding has Mammoth Biosciences raised?
Mammoth Biosciences has raised a total of $474M in funding. The most recent round on record is Funding Round.
Where is Mammoth Biosciences headquartered?
Mammoth Biosciences is headquartered in Brisbane, United States.
When was Mammoth Biosciences founded?
Mammoth Biosciences was founded in 2017.
What industry does Mammoth Biosciences operate in?
Mammoth Biosciences operates in Biotechnology, Drug Discovery, Genomics, CRISPR Technology, Gene Editing, Molecular Diagnostics.
How many employees does Mammoth Biosciences have?
Mammoth Biosciences has approximately 165 people on record.